Trimethoprim-sulfamethoxazole plus amikacin as first-line therapy and imipenem/cilastatin as second empirical therapy in febrile neutropenic patients with hematological disorders. [electronic resource]
Producer: 19920817Description: 99-106 p. digitalISSN:- 1120-009X
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Amikacin -- therapeutic use
- Bacterial Infections -- drug therapy
- Bone Marrow Transplantation
- Cilastatin -- therapeutic use
- Cilastatin, Imipenem Drug Combination
- Drug Combinations
- Drug Therapy, Combination -- therapeutic use
- Female
- Fever -- drug therapy
- Hematologic Diseases -- blood
- Humans
- Imipenem -- therapeutic use
- Leukemia -- complications
- Lymphoma -- complications
- Male
- Middle Aged
- Neutropenia -- complications
- Pneumocystis Infections -- drug therapy
- Sepsis -- drug therapy
- Trimethoprim, Sulfamethoxazole Drug Combination -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.